Sunshine Biopharma introduces new generic drugs in Canada
Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company currently valued at $5.8 million and showing promising revenue growth of 62% over the last twelve months, announced the release of two ...
MSN による配信14 日
Poor Mental Health Rising; Eating Disorder Uncertainties; Dementia Life Expectancy
Three U.S. health surveys indicated increasing prevalence of poor mental health from 2011 to 2022. (JAMA Network Open) The FDA is reviewing whether investigational suzetrigine-- billed as a ...